APA2026 banner 

21st Applied Pharmaceutical Analysis (APA) Conference

September 14-15-16, 2026

Sanofi, Cambridge

 

   

 

 

 Chongwoo Yu

 

Plenary Speaker

Chongwoo Yu, PhD

DCEP/OCP/OTS/CDER @ US Food and Drug Administration

Regulatory Perspectives on Biomarker Bioanalysis 

 

 

     
         
 Heather Myler APA2019

Heather Myler, PhD

Senior Director, Head of Immunogenicity & New Modalities @ Takeda

 The degree of validation needed for quantitative decision-making 

biomarkers vs more exploartory biomarkers - title TBA

   Ron Bowsher

 Ronald Bowsher, PhD

Partner & CSO @ B2S Life Sciences

Immunogenicity of peptides - method development, positive control generation dealing with low positive rates - title TBA

         
 Jenny Valentine

Jenny Valentine, PhD

Senior Principal Scientist @ Regeneron

A Streamlined Approach to Immunogenicity Assessment: From Analysis to Submission

  Jason DelCarpini 

Jason DelCarpini, PhD

Director, Bioanalysis & Molecular Assays @ Moderna

Real-world applications of AI in BA for small and large molecules - title TBA 

         
 Sarah Bean

Sarah Bean, PhD

Senior Director Laboratory Sciences @ Charles River Laboratories 

   Jeongsup Shim

Jeongsup Shim, PhD

Senior Principal Scientist @ Genentech

Simplifying PK and Biomarker Analysis: High-Sensitivity Single-Dilution Assays With The NULISA Platform 

         
         
         

 

 

2026 Regulated Bioanalysis Workshop 

Session I: Regulatory & Agency Perspectives

Session II: Emerging Technologies in Bioanalysis & Next Generation Modalities

Session III: Immunogenicity & ADA in Regulated Context

Session IV: AI/ML in Regulated Bioanalysis

 

2026 Discovery Bioanalysis and New Technologies Workshop 

Session I: Discovery BA for Oligonucleotide Therapeutics & Antibody-Conjugated Platforms

Session II: Discovery BA for Complex & Emerging Therapeutic Modalities

Session III: Biomarkers & Multi-Omics in Discovery

Session IV: Case Studies on Novel Technologies & Implementation

 

2026 Mechanistic ADME Workshop 

Session I: New Approach Methodology for Drug Metabolism & Toxicity

Session II: Mechanistic Insights Into Drug Metabolism, Human Metabolites, and Predictive Models

Session III: Mechanistic ADME of Emerging Therapeutic Modalities

Session IV: Mechanistic ADME for Dose and Exposure Prediction

 

 

 

DOWNLOAD 2025 APA PROGRAM GUIDE

APA 2026 Program

 

PLENARY LECTURE

 

 

       
 

PLENARY LECTURE

 

 

 

       
     

 

       
       

 

 Join our Linkedin Group:

Workshops

Regulated Bioanalysis

Discovery

Mechanistic ADME

Registration

Click here to register for the APA 2025 conference.

APA 2025 will take place October 6-8, 2025

Sanofi, Cambridge, MA

 

The Boston Society

The Boston Society (R) is an internationally-recognized NON-PROFIT organization dedicated to bringing the best scientific ideas to industrial practice through focused, timely workshops and conferences. 501(c)3

Updates

Sign Up Today!

Privacy Policy